米国企業
Bionik Laboratories Corp.

Bionik Laboratories Corp.BNKL

時価総額

$12.48

PER

	2011年 12月31日	2014年 12月31日	2015年 12月31日	2017年 3月31日	2018年 3月31日	2019年 3月31日	2020年 3月31日	2021年 3月31日	2022年 3月31日	2023年 3月31日
Cash and cash equivalents	12,455	-	7	543,650	507,311	446,779	2	1	2	0
Accounts receivable	-	-	-	383,903	212,730	2	846,964	451,905	274,844	453,084
Prepaid expenses and other current assets	-	-	188,217	228,047	433,655	1	2	2	1	862,603
Inventories	-	-	-	228,249	237,443	405,682	1	692,163	1	1
Total current assets	12,455	3,242	7	1	1	4	6	3	5	3
Equipment	-	-	87,103	227,421	159,961	192,528	154,144	93,577	91,234	187,673
Other assets	-	-	-	-	-	-	-	-	-	8,694
Operating Lease, Right-of-Use Asset	-	-	-	-	-	-	-	-	-	254,650
Tradenames and Trademarks	-	-	-	-	-	-	-	-	-	34,000
Goodwill	-	-	-	22	22	22	11	4	-	99,552
Total assets	12,455	3,242	7	29	29	31	19	9	5	3
Accounts payable	-	-	134,718	784,726	724,673	1	857,093	454,809	305,095	557,610
Accrued liabilities	332	-	57,840	1	2	2	2	760,026	873,030	1
Operating leases, current	-	-	-	-	-	-	-	-	-	22,067
Deferred Revenue, Current	-	-	-	-	-	-	616,063	268,083	313,854	342,354
Total current liabilities	6,332	42,580	-	6	8	3	5	4	1	2
Operating leases, non-current	-	-	-	-	-	-	-	-	-	234,448
Deferred revenue, net of current portion	-	-	-	-	-	-	-	303,917	256,646	303,292
Convertible notes	-	-	-	-	-	-	-	-	-	2
Total liabilities	6,332	42,580	6	-	-	-	-	6	2	5
Preferred Stock, Value, Issued	-	-	-	-	-	-	-	-	-	-
Common Stock, Value, Issued	4,989	-	72,428	96,794	249,599	3,858	5,126	5,702	6,879	6,989
Additional paid-in capital	13,661	-71,377	11	39	56	74	85	88	98	99
Accumulated deficit	-	-	-10,647,888	-15,588,554	-35,776,340	-46,357,373	-71,373,870	-84,994,327	-95	-100
Accumulated other comprehensive income	-	-	42,149	42,149	42,149	42,149	42,149	42,149	28,096	29,815
Total stockholders' (deficit) equity	6,123	-39,338	977,988	23	20	27	13	3	3	-1,640,588
Total liabilities and stockholders' equity	12,455	3,242	7	29	29	31	19	9	5	3